Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

84.66
BATS BZX Real-Time Price
As of 2:47pm ET
 +2.02 / +2.44%
Today’s Change
64.18
Today|||52-Week Range
86.72
+15.11%
Year-to-Date
Why You Should Add Novo Nordisk Stock to Your Portfolio
11:43am / Zacks.com - Paid Partner Content
Cramer: You Can't Bet Against the Bonds
Jun 16 / TheStreet.com - Paid Partner Content
Merck's Keytruda on a Roll: Can it Retain the Momentum?
10:51am / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: GE Appoints Flannery as CEO; UTX, CAT Hike Dividends
Jun 16 / Zacks.com - Paid Partner Content
Novo Nordisk's Victoza Gets FDA Panel Nod for Label Expansion
Jun 21 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J, Lilly Present Data, Merck Keytruda Study Enrolment Paused
Jun 16 / Zacks.com - Paid Partner Content
5 Reasons Why You Should Invest in AstraZeneca (AZN) in 2017
Jun 20 / Zacks.com - Paid Partner Content
Why Is ImmunoGen (IMGN) Stock Up 131% This Year?
Jun 15 / Zacks.com - Paid Partner Content
On Betting Against the Bonds and Panicking off the Fed: Jim Cramer's Best Blog
Jun 16 / TheStreet.com - Paid Partner Content
J&J's Invokana Lowers Heart Issues, Raises Amputation Risk
Jun 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close82.64
Today’s open82.95
Day’s range82.88 - 84.75
Volume232,831
Average volume (3 months)3,843,129
Market cap$91.2B
Dividend yield2.46%
Data as of 2:47pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)+14.16%
Earnings growth (this year)+16.88%
Earnings growth (next 5 years)+13.40%
Revenue growth (last year)+6.33%
P/E ratio40.9
Price/Sales3.68
Price/Book6.49

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+1.28+2.29%
AZNAstraZeneca+0.61+1.75%
ABTAbbott Laboratories+0.67+1.38%
NVONovo Nordisk-0.01-0.02%
Data as of 2:47pm ET, 06/22/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)$1.05
Annual revenue (last year)$21.2B
Annual profit (last year)$2.7B
Net profit margin12.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts